Emerging Microbes and Infections (Jan 2014)

The quest for effective Ebola treatment: Ebola VP35 is an evidence-based target for dsRNA drugs

William M Mitchell,
William A Carter

Affiliations

William M Mitchell: Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN 37232, USA
William A Carter: Hemispherx Biopharma, Inc., Philadelphia, PA 19103, USA

DOI: https://doi.org/10.1038/emi.2014.77
Journal volume & issue: Vol. 3, no. 1
pp. 1 – 2

Abstract

No abstracts available.

Published in Emerging Microbes and Infections

ISSN: 2222-1751 (Online)
Publisher: Taylor & Francis Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases; Science: Microbiology
Website: https://www.tandfonline.com/journals/temi

About the journal